Targeting Iron Regulatory Protein 2 in Tumor-associated Macrophages Activates Antitumor Immunity in NSCLC via Modulating SphK1-PD-L1 Axis
Jiawen Ding, Qinpei Cheng, Chen Cheng, Ying Mei, Liu Yang, Peilin Chen, Lei Zheng, Suhua Zhu, Kaikai Shen, Kuanyu Li, Tangfeng Lv · 2026
Read Targeting Iron Regulatory Protein 2 in Tumor-associated Macrophages Activates Antitumor Immunity in NSCLC via Modulating SphK1-PD-L1 Axis by Jiawen Ding, Qinpei Cheng, Chen Cheng, Ying Mei, Liu Yang, Peilin Chen, Lei Zheng, Suhua Zhu, Kaikai Shen, Kuanyu Li, Tangfeng Lv (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13618223.txt.
Description
Jiawen Ding and co-authors study a protein called IRP2 in lung cancer in a 2026 paper. The cancer type is non-small cell lung cancer, the top cause of cancer death in the world. Around tumors sit macrophages, immune cells that can help or hinder the fight. The team found that IRP2, a protein that controls iron inside cells, is high in many tumors. They asked what it does in those immune cells.
The results paint IRP2 as a brake on immune attack. With more IRP2, the immune cells shifted to a state that helps tumors grow and spread. The protein also kept PD-L1, a shield tumors use, at high levels on the cells. It did so by slowing the breakdown of a partner protein in cell waste units. Blocking IRP2 in these cells is put forward as a fresh drug aim for this cancer.
Catalog record
| CREATOR | Jiawen Ding, Qinpei Cheng, Chen Cheng, Ying Mei, Liu Yang, Peilin Chen, Lei Zheng, Suhua Zhu, Kaikai Shen, Kuanyu Li, Tangfeng Lv |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |